Validation of translated hindi and marathi versions of famcare-2 tool for measuring family satifaction in families of children with advanced cancer.
Not Applicable
- Registration Number
- CTRI/2017/11/010313
- Lead Sponsor
- Self
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Parent or guardian or legally acceptable representative of children Suffering from metastatic solid tumour or relapse or recurrent hematolymphoid cancer.
Exclusion Criteria
1.Not able to understand Hindi or Marathi.
2.Participants not willing to consent
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To demonstrate that the Hindi and Marathi versions of FAMCARE-2 are valid and reliable in describing family satisfaction among families of children aged 0 to 18 years with a locally advanced or metastatic solid organ cancer, or a relapsed or refractory hematolymphoid cancer, who are receiving palliative care.Timepoint: at first visit to palliative medicine OPD after start of study period from 23.10.2017 upto 22.12.2017
- Secondary Outcome Measures
Name Time Method 1)To establish the content validity ratio, inter subscale correlation of the Hindi and Marathi translated versions of FAMCARE-2 tool. <br/ ><br>2)To establish the reliability of the translated versions of FAMCARE-2 tool. measured by evaluating internal consistency using CRONBACHâ??S of alpha.Timepoint: at first visit to palliative medicine OPD from the start of the study on 23.10.2017 upto 22.12.2017
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie family satisfaction in advanced paediatric cancer care?
How does Famcare-2 compare to other family satisfaction assessment tools in oncology?
Are there specific biomarkers associated with family satisfaction in pediatric cancer patients?
What adverse events are commonly reported in families of children with advanced cancer and how are they managed?
What are the current therapeutic approaches for advanced pediatric cancer and how does family satisfaction impact treatment outcomes?